You are currently viewing a new version of our website. To view the old version click .
Pharmaceutics
  • Correction
  • Open Access

28 October 2022

Correction: Nguyen et al. Oligonucleotide Solid Nucleolipid Nanoparticles against Antibiotic Resistance of ESBL-Producing Bacteria. Pharmaceutics 2022, 14, 299

,
,
,
,
,
,
,
,
and
1
ARNA, Inserm U1212, CNRS 5320, University of Bordeaux, 146 Rue Léo Saignat, CEDEX, 33076 Bordeaux, France
2
UMR 5026, University of Bordeaux, CNRS, Bordeaux-INP, ICMCB, 87 Avenue du Dr Albert Schweitzer, CEDEX, 33608 Pessac, France
3
MFP, CNRS 5234, University of Bordeaux, 146 Rue Léo Saignat, CEDEX, 33076 Bordeaux, France
*
Author to whom correspondence should be addressed.

Error in Figure

In the original publication [], there was a mistake in Figure 1 as published. The chemical formulae of nucleolipids, i.e., DOTAU and diC16dT, did not display correctly, as the repeats of carbon atoms in the lipid chain (parenthesis and number of repeats) were missing. The corrected Figure 1 appears below. The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated. Pharmaceutics 14 02317 i001

Reference

  1. Nguyen, P.V.; Aubry, C.; Boudaoud, N.; Gaubert, A.; Langlois, M.-H.; Marchivie, M.; Gaudin, K.; Arpin, C.; Barthélémy, P.; Kauss, T. Oligonucleotide Solid Nucleolipid Nanoparticles against Antibiotic Resistance of ESBL-Producing Bacteria. Pharmaceutics 2022, 14, 299. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.